The aim of the 15th International Congress On Neuromuscular Disease is to present a wide spectrum of neuromuscular diseases from the perspectives of advances in research, diagnosis and treatment.
Dr Virginia Arechavala and Patricia Soblechero attended the Congress and presented our work on CRISPR/Cas gene editing for in Duchenne muscular dystrophy cultures to test new treatments for the disease and Myoblots for the evaluation of new treatments in neuromuscular disorders.
